An analysis of over 1.2 million gynecologic cancer cases revealed a trend towards surgical de-escalation, with researchers observing a growing shift to minimally invasive techniques and sentinel lymph ...
Although targeted therapies and immunotherapy have improved survival outcomes in many patients with lung cancer, these therapies come at a cost, not only financially but also in terms of cumulative ...
In early-stage breast cancer (EBC), multimodal therapy de-escalation strategies are feasible without compromising outcomes but need to be discussed by a multidisciplinary team. In hormone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results